Literature DB >> 8388296

The effect of lifarizine (RS-87476), a novel sodium and calcium channel modulator, on ischaemic dopamine depletion in the corpus striatum of the gerbil.

C M Brown1, C Calder, B J Alps, M Spedding.   

Abstract

1. Unilateral ligation of the right common carotid artery in the anaesthetized gerbil for 3 h caused a 62.7% decrease in ipsilateral dopamine in the corpus striatum from 1.40 (+/- 0.13, n = 27) micrograms g-1 in the non-ischaemic hemisphere to 0.47 (+/- 0.07, n = 27) micrograms g-1 in the ischaemic hemisphere (all results are expressed as mean +/- s.e. mean). In sham-operated animals there were no differences in the dopamine levels (1.31 +/- 0.14 micrograms g-1, n = 11, left; 1.27 +/- 0.13 micrograms g-1, n = 11 in the right hemisphere). Animals with intact communicating arteries in the circulus arteriosus were excluded. 2. Lifarizine (RS-87476; 250, 500, but not 50, micrograms kg-1, i.p.) protected against this dopamine depletion showing only a 9.2% decrease at 250 micrograms kg-1, i.p. (P < 0.01) and no decrease at 500 micrograms kg-1, i.p. (P < 0.01). 3. Nicardipine (250 micrograms kg-1, p.o.) was effective when administered chronically once daily for 10 days (26.6% decrease, P < 0.05) but not when administered acutely at 50 micrograms kg-1, i.p.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388296      PMCID: PMC2175597          DOI: 10.1111/j.1476-5381.1993.tb13549.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Downregulation of sodium channels during anoxia: a putative survival strategy of turtle brain.

Authors:  M A Pérez-Pinzón; M Rosenthal; T J Sick; P L Lutz; J Pablo; D Mash
Journal:  Am J Physiol       Date:  1992-04

2.  Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats.

Authors:  J C Grotta; L C Pettigrew; D Rosenbaum; C Reid; H Rhoades; D McCandless
Journal:  Stroke       Date:  1988-04       Impact factor: 7.914

Review 3.  Historical overview. Calcium, ischemia, and death of brain cells.

Authors:  B K Siesjö
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  The potential beneficial effect of nicardipine in a rat model of transient forebrain ischemia.

Authors:  B J Alps; W K Hass
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

5.  Brain extraction of a calcium channel blocker.

Authors:  J C Grotta; L C Pettigrew; A H Lockwood; C Reid; C Reich
Journal:  Ann Neurol       Date:  1987-02       Impact factor: 10.422

6.  Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection.

Authors:  B M Eriksson; B A Persson
Journal:  J Chromatogr       Date:  1982-03-12

7.  Reduction in brain dopamine following experimental cerebral ischaemia.

Authors:  N T Zervas; H Hori; M Negora; R J Wurtman; F Larin; M H Lavyne
Journal:  Nature       Date:  1974-02-01       Impact factor: 49.962

8.  Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome.

Authors:  I Saito; H Segawa; Y Shiokawa; M Taniguchi; K Tsutsumi
Journal:  Stroke       Date:  1987 Sep-Oct       Impact factor: 7.914

9.  Occlusive disease of the middle cerebral artery.

Authors:  L Caplan; V Babikian; C Helgason; D B Hier; D DeWitt; D Patel; R Stein
Journal:  Neurology       Date:  1985-07       Impact factor: 9.910

10.  Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes.

Authors:  T Brannan; J Weinberger; P Knott; I Taff; H Kaufmann; D Togasaki; J Nieves-Rosa; H Maker
Journal:  Stroke       Date:  1987 Jan-Feb       Impact factor: 7.914

View more
  6 in total

1.  Neuroprotective efficacy of lifarizine (RS-87476) in a simplified rat survival model of 2 vessel occlusion.

Authors:  D E McBean; V Winters; A D Wilson; C B Oswald; B J Alps; J M Armstrong
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Actions of the novel neuroprotective agent, lifarizine (RS-87476), on voltage-dependent sodium currents in the neuroblastoma cell line, N1E-115.

Authors:  J G McGivern; L Patmore; R D Sheridan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

3.  [3H]-lifarizine, a high affinity probe for inactivated sodium channels.

Authors:  A C MacKinnon; K M Wyatt; J G McGivern; R D Sheridan; C M Brown
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

4.  Neuroprotective profile of lifarizine (RS-87476) in rat cerebrocortical neurones in culture.

Authors:  G R May; W S Rowand; J G McCormack; R D Sheridan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Reduction by lifarizine of the neuronal damage induced by cerebral ischaemia in rodents.

Authors:  B J Alps; C Calder; A D Wilson; D E McBean; J M Armstrong
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

6.  Inhibition by lifarizine of intracellular Ca2+ rises and glutamate exocytosis in depolarized rat cerebrocortical synaptosomes and cultured neurones.

Authors:  D C Budd; G R May; D G Nicholls; J G McCormack
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.